SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : OSI Pharmaceuticals (OSIP) - formerly Oncogene -- Ignore unavailable to you. Want to Upgrade?


To: Miljenko Zuanic who wrote (182)10/15/2002 9:16:50 AM
From: tuck  Read Replies (1) | Respond to of 447
 
From> Briefing.com:

>>7:26AM AstraZeneca: Iressa deaths reported in Japan (AZN) 36.60: Japan's health ministry last night linked 13 deaths to side effects of AZN's Iressa lung cancer treatment; Reuters reports that the company will address the issue by making side effects more clear in the labelling, but stands by the safety of Iressa.<<

Cheers, Tuck